Abstract
cRaf-1 is a mitogen-activated protein kinase that is the main effector recruited by GTP-bound Ras in order to activate the MAP kinase pathway1. Inactive Raf is found in the cytosol in a complex with Hsp90, Hsp50 (Cdc37)2,3 and the 14-3-3 proteins4. GTP-bound Ras binds Raf and is necessary but not sufficient for the stable activation of Raf that occurs in response to serum, epidermal growth factor, platelet-derived growth factor or insulin5,6,7,8. These agents cause a two- to threefold increase in overall phosphorylation of Raf on serine/threonine residues8,9, and treatment of cRaf-1 with protein (serine/threonine) phosphatases can deactivate it, at least partially10. The role of 14-3-3 proteins in the regulation of Raf's kinase activity is uncertain4,11 and is investigated here. Active Raf can be almost completely deactivated in vitro by displacement of 14-3-3 using synthetic phosphopeptides. Deactivation can be substantially reversed by addition of purified recombinant bacterial 14-3-3; however, Raf must have been previously activated in vivo to be reactivated by 14-3-3 in vitro. The ability of 14-3-3 to support Raf activity is dependent on phosphorylation of serine residues on Raf and on the integrity of the 14-3-3 dimer; mutant monomeric forms of 14-3-3, although able to bind Raf in vivo, do not enable Raf to be activated in vivo or restore Raf activity after displacement of 14-3-3 in vitro. The 14-3-3 protein is not required to induce dimerization of Raf. We propose that dimeric 14-3-3 is needed both to maintain Raf in an inactive state in the absence of GTP-bound Ras and to stabilize an active conformation of Raf produced during activation in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Avruch, J., Zhang, X. F., Kyriakis, J. M. Ras meets Raf: completing the framework of a signal transduction pathway. Trends Biochem. Sci. 19, 279–283 (1994).
Stancato, L. F. et al. Raf exists in a native heterocomplex with hsp90 and hsp50 that can be reconstituted in a cell-free system. J. Biol. Chem. 268, 21711–21716 (1993).
Wartmann, M. & Davis, R. J. The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex. J. Biol. Chem. 269, 6695–6701 (1994).
Aitken, A. 14-3-3 and its possible role in co-ordinating multiple signalling pathways. Trends Cell Biol. 6, 341–347 (1996).
Marshall, C. J. Ras Effectors. Curr. Opin. Cell Biol. 89, 197–204 (1996).
Zhang, X.-F. et al. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 364, 308–313 (1993).
Stokoe, D. & McCormick, F. Activation of cRaf-1 by Ras and Src through different mechanisms: activation in vivo and in vitro. EMBO J. 16, 2384–2396 (1997).
Kyriakis, J. M., Force, T. L., Rapp, U. R., Bonventre, J. V. & Avruch, J. Mitogen regulation of c-Raf-1 protein kinase activity toward mitogen-activated protein kinase-kinase. J. Biol. Chem. 268, 16009–16019 (1993).
Morrison, D. K., Heidecker, G., Rapp, U. R. & Copeland, T. D. Identification of the major phosphorylation sites of the Raf-1 kinase. J. Biol. Chem. 268, 17309–17316 (1993).
Dent, P., Jelinek, T., Morrison, D. K., Weber, M. J. & Sturgill, T. W. Reversal of Raf-1 activaiton by purified and membrane-associated protein phosphatases. Science 268, 1902–1906 (1995).
Morrison, D. & Cutler, R. E. J The complexity of Raf-1 regulation. Curr. Opin. Cell Biol. 9, 174–179 (1997).
Chang, H. C. & Rubin, G. M. 14-3-3ε positively regulates Ras-mediated signalling in Drosophila. Genes Dev. 11, 1132–1139 (1997).
Knockel, L., Vorbruggen, G., Jacklem, H., Mlodzik, M. & Bohmann, D. Requirement for Drosophila 14-3-3ζ in Raf-dependent photoreceptor development. Genes Dev. 11, 1140–1147 (1997).
Freed, E., Symons, M., Macdonald, S. G., McCormick, F. & Ruggieri, R. Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science 265, 1713–1716 (1994).
Irie, K. et al. Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase. Science 265, 1716–1719 (1994).
Fantl, W. J. et al. Activation of Raf by 14-3-3 proteins. Nature 371, 612–614 (1994).
Muslin, A. J., Tanner, J. W., Allen, P. M. & Shaw, A. S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84, 889–898 (1996).
Luo, Z.-J., Zhang, X.-F., Rapp, U. & Avruch, J. Identification of the 14-3-3ζ domains important for self-association and Raf binding. J. Biol. Chem. 270, 23681–23687 (1995).
Michaud, N. R., Fabian, J. R., Mathes, K. D. & Morrison, D. K. 14-3-3 is not essential for Raf-1 function: identification of cRaf-1 proteins that are biologically activated in a 14-3-3 and Ras-independent manner. Mol. Cell Biol. 15, 3390–3397 (1995).
Fu, H. et al. Interaction of the protein kinase Raf-1 with 14-3-3 proteins. Science 266, 126–129 (1994).
Suen, K.-L., Bustelo, X. R. & Barbacid, M. Lack of evidence for the activation of the Ras/Raf mitogenic pathway by 14-3-3 proteins in mammalian cells. Oncogene 11, 825–831 (1995).
Clark, G. J. et al. 14-3-3ζ negatively regulates Raf-1 activity by interactions with the Raf-1 cysteine-rich domain. J. Biol. Chem. 272, 20990–20993 (1997).
Rommel, C., Radziwill, G., Moelling, K. & Hafen, E. Negative regulation of Raf activity by binding 14-3-3 to the aminoterminus of Raf in vivo. Mech. Dev. 4, 95–104 (1997).
Luo, Z.-J., Tzivion, G., Belshaw, P. J., Marshall, M. & Avruch, J. Oligomerization activates c-Raf-1 through a Ras-dependent mechanism. Nature 383, 181–185 (1996).
Farrar, M. A., Alberol-Ila & Perimutter, R. M. Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. Nature 383, 178–181 (1996).
Liu, D. et al. Crystal structure of the zeta isoform of the 14-3-3 protein. Nature 376, 191–194 (1995).
Rommel, C. et al. Activated Ras displaces 14-3-3 protein from the aminoterminus of cRaf-1. Oncogene 12, 609–619 (1996).
Durfee, T. et al. The Retinoblastoma protein associates with protein phosphatase type 1 catalytic subunit. Genes Dev. 7, 555–569 (1993).
Acknowledgements
The authors were supported by a grant from Eli Lilly, Inc. We thank A. Khatri for peptide synthesis and purification, and J. Prendable for preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tzivion, G., Luo, Z. & Avruch, J. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 394, 88–92 (1998). https://doi.org/10.1038/27938
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/27938
This article is cited by
-
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies
Nature Reviews Cancer (2024)
-
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Molecular Cancer (2023)
-
A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma
Journal of Experimental & Clinical Cancer Research (2021)
-
A structural model of a Ras–Raf signalosome
Nature Structural & Molecular Biology (2021)
-
Negative regulation of RAF kinase activity by ATP is overcome by 14-3-3-induced dimerization
Nature Structural & Molecular Biology (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.